Roche Profitability Beats Expectations

Dow Jones07-23

1251 GMT - Roche Holding's first-half results show impressive profitability for the Swiss drugmaker due to cost savings and lower-than-expected spending on research and development, Bernstein analysts say in a research note. The company's first-half core operating profit of 11.9 billion Swiss francs beat consensus estimates by 4%, with a 39% margin that was 142 basis points ahead of the consensus, according to Bernstein. Roche achieved that level of profitability by optimizing research-and-development investment, while savings reduced its selling, general and administration expenses, the analysts say. Nevertheless, the company reiterated its full-year guidance and consensus estimates seem unlikely to change, they add. Shares rise 1.9%. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

July 23, 2026 08:52 ET (12:52 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2653172897?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-23 20:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653172897","market":"us","top_or_hot":-1,"title":"Roche Profitability Beats Expectations","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1251 GMT - Roche Holding's first-half results show impressive profitability for the Swiss drugmaker due to cost savings and lower-than-expected spending on research and development, Bernstein analysts say in a research note. The company's first-half core operating profit of 11.9 billion Swiss francs beat consensus estimates by 4%, with a 39% margin that was 142 basis points ahead of the consensus, according to Bernstein. Roche achieved that level of profitability by optimizing research-and-development investment, while savings reduced its selling, general and administration expenses, the analysts say. Nevertheless, the company reiterated its full-year guidance and consensus estimates seem unlikely to change, they add. Shares rise 1.9%. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 23, 2026 08:52 ET (12:52 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roche Profitability Beats Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoche Profitability Beats Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-23 20:52</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1251 GMT - Roche Holding's first-half results show impressive profitability for the Swiss drugmaker due to cost savings and lower-than-expected spending on research and development, Bernstein analysts say in a research note. The company's first-half core operating profit of 11.9 billion Swiss francs beat consensus estimates by 4%, with a 39% margin that was 142 basis points ahead of the consensus, according to Bernstein. Roche achieved that level of profitability by optimizing research-and-development investment, while savings reduced its selling, general and administration expenses, the analysts say. Nevertheless, the company reiterated its full-year guidance and consensus estimates seem unlikely to change, they add. Shares rise 1.9%. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 23, 2026 08:52 ET (12:52 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HRTS","symbol_name":"Tema Heart & Health ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2653172897","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653172897","pubTimestamp":1784811120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1251 GMT - Roche Holding's first-half results show impressive profitability for the Swiss drugmaker due to cost savings and lower-than-expected spending on research and development, Bernstein analysts say in a research note. The company's first-half core operating profit of 11.9 billion Swiss francs beat consensus estimates by 4%, with a 39% margin that was 142 basis points ahead of the consensus, according to Bernstein. Roche achieved that level of profitability by optimizing research-and-development investment, while savings reduced its selling, general and administration expenses, the analysts say. Nevertheless, the company reiterated its full-year guidance and consensus estimates seem unlikely to change, they add. Shares rise 1.9%.  Dow Jones NewswiresJuly 23, 2026 08:52 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HRTS":"Tema Heart & Health ETF","CANC":"TEMA ONCOLOGY ETF","RHHBY":"罗氏控股","03165":"华夏欧优股对冲","BK4007":"制药"},"translate_title":"罗氏盈利能力超出预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HRTS":0.6,"CANC":0.6,"RHHBY":0.9,"03165":0.6},"content_text":"1251 GMT - Roche Holding's first-half results show impressive profitability for the Swiss drugmaker due to cost savings and lower-than-expected spending on research and development, Bernstein analysts say in a research note. The company's first-half core operating profit of 11.9 billion Swiss francs beat consensus estimates by 4%, with a 39% margin that was 142 basis points ahead of the consensus, according to Bernstein. Roche achieved that level of profitability by optimizing research-and-development investment, while savings reduced its selling, general and administration expenses, the analysts say. Nevertheless, the company reiterated its full-year guidance and consensus estimates seem unlikely to change, they add. Shares rise 1.9%. (adria.calatayud@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 23, 2026 08:52 ET (12:52 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2653172897","isCrawlerRequest":true}